Eckert & Ziegler to supply therapeutic radioisotopes to Nucleus Radiopharma

Eckert & Ziegler signed extensive supply agreements to serve as core supplier of Lutetium-177 and Actinium-225 to Nucleus Radiopharma for use in cancer treatment radiopharmaceuticals.

“We are pleased to support Nucleus’ activities with our Actinium-225 and Lutetium-177 supply and thus contribute to the advancement of radiotherapies.”lesechos-comfi.lesechos.fr

• 1 source
• lesechos-comfi.lesechos.frEckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ) |Eckert, Ziegler Strahlen- Und Medizintechnik AGJan 31, 2024

Summarized from public sources; check the original articles before acting on it.